Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a fixed-dose combination of ledipasvir/sofosbuvir for chronic hepatitis C genotype 1, focusing on cerebral metabolism and neurocognitio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2016-11-30